HERON THERAPEUTICS, INC. /DE/ Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Heron Therapeutics, Inc. /De/ quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q2 2024.
  • Heron Therapeutics, Inc. /De/ Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $4.72M, a 36% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.72M -$2.66M -36% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.5M -$2.86M -34.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $6.29M -$2.81M -30.8% Dec 31, 2023 10-K 2024-03-12
Q3 2023 $7.06M -$2.76M -28.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $7.37M -$3.17M -30.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $8.36M -$2.91M -25.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $9.1M -$2.89M -24.1% Dec 31, 2022 10-K 2023-03-29
Q3 2022 $9.83M -$8.06M -45% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $10.5M -$8.32M -44.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $11.3M -$8.58M -43.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $12M -$8.85M -42.5% Dec 31, 2021 10-K 2022-02-28
Q3 2021 $17.9M -$3.91M -18% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $18.9M -$3.89M -17.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $19.8M -$3.86M -16.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $20.8M +$3.32M +19% Dec 31, 2020 10-K 2021-02-24
Q3 2020 $21.8M +$6.63M +43.7% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $22.8M +$6.86M +43.2% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $23.7M +$6.8M +40.2% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $17.5M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $15.2M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $15.9M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $16.9M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.